Tag Archives: Sanofi

FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista

The FDA stiff-armed Sanofi and Lexicon’s diabetes drug Zynquista on Friday, darkening the companies’ hopes of launching the drug for Type 1 diabetes this year. It’s not a complete surprise, because an FDA advisory panel was split right down the middle on whether to approve the SGLT1/2 drug. But the FDA could have chosen the positive side… Read More »